The Discounted Cash Flow (DCF) valuation of Royalty Pharma PLC (RPRX) is 38.70 USD. With the latest stock price at 24.84 USD, the upside of Royalty Pharma PLC based on DCF is 55.8%.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 7.7% | 6.3% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 16.65 - 323.88 | 38.70 |
| Upside | -33.0% - 1203.9% | 55.8% |